Your session is about to expire
← Back to Search
IOK Therapy for PTSD (IOK Trial)
IOK Trial Summary
This trial is testing whether a new treatment called Impact of Killing (IOK) is more effective than present-centered therapy (PCT) for treating post-traumatic stress disorder (PTSD) in veterans.
IOK Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IOK Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still opportunities for volunteers to partake in this research?
"Affirmative. As per the information on clinicaltrials.gov, this research trial is actively looking for participants to take part in it; the study was first posted on August 12th 2019 and last updated July 1st 2022. It requires 95 individuals from 2 medical centres to be enrolled."
Is the enrollment criteria for this trial limited to individuals aged fifty and below?
"Per the inclusion criteria, participants in this trial must be between 18 and 82 years of age."
Is enrollment available for this research study?
"This research trial is recruiting 95 veterans suffering from moral injury, aged 18 to 82. Qualifying criteria includes having experienced killing or death in a warzone with continued distress; DSM-5 PTSD diagnosis or CAPS score of 23+; positive response to at least one item on the EMIS-M scale or MIES #4; completion and two weeks waiting period after CPT/PE treatment if undergoing therapy; 1 month stability on prescription medications for PTSD without any changes during active phase of study and initiation/completion of evidence based treatments such as CPT/PE."
What is the current participant headcount of this clinical research?
"Affirmative, clinicaltrials.gov indicates that this trial is still on-going and actively seeking participants since it was posted in August 12th 2019 with the latest update occurring July 1st 2022. The project necessitates 95 patients to be recruited from two distinct locales."
Share this study with friends
Copy Link
Messenger